# Reconstruction of the Diabetic Foot

## Introduction
Diabetic foot ulcers (DFUs) affect 15-25% of diabetic patients during their lifetime. Diabetes is the leading cause of nontraumatic lower extremity amputation; 85% of amputations are preceded by a foot ulcer. Multidisciplinary management (plastic surgery, vascular surgery, endocrinology, podiatry, orthotics, wound care) is essential. The goal is limb salvage with a functional, plantigrade, sensate (when possible) foot that allows ambulation. Prevention through patient education, glycemic control, and regular foot screening reduces amputation rates by 50-85%.

## Pathophysiology of the Diabetic Foot

### Neuropathy
**Peripheral sensory neuropathy**: most important factor in DFU development; loss of protective sensation allows repetitive unrecognized trauma. Semmes-Weinstein monofilament (5.07/10g): inability to detect indicates loss of protective sensation. **Motor neuropathy**: denervation of intrinsic foot muscles → muscle imbalance → claw toe and hammer toe deformities → metatarsal head prominence → abnormal pressure points. **Autonomic neuropathy**: loss of sudomotor function → dry, cracked skin → portal for infection; loss of sympathetic vascular tone → arteriovenous shunting → paradoxically warm but poorly perfused foot.

### Vasculopathy
**Peripheral arterial disease (PAD)**: affects 50% of diabetic patients with foot ulcers. Pattern of disease: predominantly infrapopliteal (tibial and peroneal arteries); pedal arteries often preserved. Calcification of the tunica media (Monckeberg sclerosis): falsely elevates ABI readings. Impaired angiogenesis and collateral formation. Critical limb ischemia: rest pain, nonhealing wounds, gangrene.

### Immunopathy
Impaired neutrophil chemotaxis, phagocytosis, and bacterial killing. Hyperglycemia impairs immune function directly. Biofilm formation on chronic wounds further impairs healing.

### Charcot Neuroarthropathy
Neuropathic destruction of bones and joints leading to deformity, instability, and ulceration. Acute phase: erythema, warmth, swelling, and bounding pulses (often misdiagnosed as cellulitis or DVT). **Rocker-bottom foot deformity**: midfoot collapse with plantar prominence of cuboid/cuneiforms; creates pressure point for ulceration. Treatment: total contact casting (acute phase), custom molded shoes (chronic phase), surgical correction (severe deformity with recurrent ulceration).

## Evaluation

### Vascular Assessment
**ABI**: screening tool; however, falsely elevated in diabetics due to medial arterial calcification. ABI >1.3 is noncompressible and unreliable. **Toe pressures and toe-brachial index (TBI)**: more reliable in diabetics; digital arteries are less susceptible to calcification. TBI >0.7 and absolute toe pressure >30 mmHg suggest adequate perfusion for healing.

**Transcutaneous oxygen pressure (TcPO2)**: measures local tissue oxygenation; >40 mmHg suggests adequate healing potential; <20 mmHg indicates ischemia. **CT angiography or MR angiography**: define vascular anatomy for revascularization planning. **Vascular consultation**: revascularization (angioplasty, stenting, or bypass) should be performed before or concurrent with wound reconstruction if PAD is present.

### Wound Assessment

| Wagner Grade | Description | Key Feature |
|-------------|-------------|-------------|
| 0 | Intact skin, bony deformity | Pre-ulcerative |
| 1 | Superficial ulcer | Skin only |
| 2 | Deep ulcer | Tendon, joint capsule, or bone exposed |
| 3 | Deep ulcer with abscess/osteomyelitis | Infection/sepsis |
| 4 | Localized gangrene | Forefoot |
| 5 | Extensive gangrene | Entire foot |

**Wagner classification**: Grade 0: intact skin, bony deformity (pre-ulcerative). Grade 1: superficial ulcer. Grade 2: deep ulcer to tendon, joint capsule, or bone.

Grade 3: deep ulcer with abscess, osteomyelitis, or joint sepsis. Grade 4: localized gangrene (forefoot). Grade 5: extensive gangrene (entire foot). **University of Texas classification**: grades ulcer depth (0-3) and stages by presence of infection and/or ischemia (A-D); more predictive of outcome than Wagner.

**Osteomyelitis assessment**: probe-to-bone test (positive predictive value 89%); ESR >70 mm/hr; MRI (most sensitive imaging); bone biopsy with culture is gold standard.

### Biomechanical Assessment
Identify deformities contributing to abnormal pressure (claw toes, metatarsal head prominence, Charcot deformity). Plantar pressure mapping if available. Assess for equinus contracture (tight Achilles tendon): common contributor to forefoot ulceration.

<image>Illustration showing the pathophysiology of diabetic foot ulceration in a cross-sectional diagram of the foot. The diagram shows three interconnected pathways leading to ulceration. The first pathway shows sensory neuropathy: an afferent nerve with demyelination and loss of sensation, depicted with a disrupted nerve signal from the plantar surface, with repetitive microtrauma from walking shown as downward arrows on the insensate sole. The second pathway shows motor neuropathy: denervated intrinsic muscles of the foot (interossei and lumbricals) depicted as atrophied, leading to claw toe deformity with the metatarsal head depressed and prominent on the plantar surface, creating an abnormal pressure point. The third pathway shows autonomic neuropathy: loss of sweat gland innervation resulting in dry cracked skin, and arteriovenous shunting shown as dilated AV connections in the dermal vasculature bypassing the capillary bed. All three pathways converge on a plantar neuropathic ulcer beneath a prominent metatarsal head. A fourth contributing factor shows peripheral arterial disease with calcified infrapopliteal arteries reducing blood flow to the foot. Labels identify each pathway, the metatarsal head, plantar ulcer, and relevant anatomic structures.</image>

## Non-Operative Management
**Offloading**: single most important intervention for plantar DFUs. Total contact cast (TCC): gold standard; redistributes pressure across the entire plantar surface; achieves 70-90% healing rates for neuropathic ulcers. Irremovable fixed ankle walking boots (equivalent efficacy to TCC). Removable walkers, therapeutic shoes, custom orthotics for maintenance.

**Wound care**: sharp debridement of callus and necrotic tissue; moist wound healing; negative pressure wound therapy for deep or surgical wounds. **Infection management**: deep tissue cultures (not superficial swabs); targeted antibiotics; surgical drainage of abscesses. **Glycemic control**: HbA1c <8% improves healing; tight perioperative glucose control (120-180 mg/dL). **Achilles tendon lengthening (percutaneous)**: for forefoot ulcers with equinus contracture; reduces plantar pressure by 27%; significantly reduces recurrence.

## Surgical Reconstruction

### Debridement
Aggressive debridement of all necrotic and infected tissue. Partial or ray amputation for gangrenous or infected toes; preserve length when possible. Metatarsal head resection for recurrent plantar ulcers under prominent metatarsal heads. Osteomyelitis: partial ostectomy with 5-10 mm margin of clean bone; or staged antibiotic-loaded cement spacer.

### Local Flaps
**Filleted toe flap**: toe is amputated and the skin and soft tissue are filleted off the bone as a flap to cover adjacent defects; provides sensate plantar tissue. **V-Y advancement flaps**: useful for small heel and plantar defects. **Plantar rotation flaps**: medial or lateral plantar flaps based on plantar arteries; provide durable, sensate, weight-bearing coverage for heel defects. Medial plantar flap (instep flap): based on the medial plantar artery; provides glabrous skin for heel reconstruction; gold standard local flap for heel defects.

### Muscle and Fasciocutaneous Flaps
**Reverse sural artery flap**: pedicled fasciocutaneous flap based on retrograde flow through the sural artery and peroneal perforators. Covers Achilles, posterior heel, lateral and medial malleolus defects. Higher complication rate in diabetic patients (venous congestion, partial necrosis). Delay procedure or supercharging (anastomosis of the sural vein to local vein) improves reliability.

**Abductor hallucis flap**: muscle flap for small medial midfoot defects. **Abductor digiti minimi flap**: muscle flap for lateral midfoot defects.

### Free Tissue Transfer
Indicated for large defects (>5 cm) or when local flap options are exhausted. Requires at least one patent pedal vessel (CTA mandatory preoperatively). **ALT flap**: workhorse free flap for dorsal foot and large plantar defects; can be thinned for contouring. **Gracilis free flap**: muscle flap with skin graft; useful for moderate defects.

**Medial plantar free flap**: from contralateral foot; provides glabrous, sensate tissue; significant donor morbidity. **Free flap outcomes in diabetics**: higher complication rates (15-25% vs. 5-10% in non-diabetics) but acceptable limb salvage rates (80-90%). Free flaps on the weight-bearing plantar surface: initially promising but long-term outcomes show breakdown due to lack of the specialized plantar skin structure.

<image>Illustration of the medial plantar (instep) flap for heel reconstruction. Panel A shows the plantar surface of the foot with the medial plantar flap outlined over the non-weight-bearing instep region of the medial arch. The medial plantar artery and nerve are labeled as the pedicle, coursing from the posterior tibial artery beneath the abductor hallucis muscle. The flap boundaries are shown: medially along the non-weight-bearing border, laterally to the midline of the sole but not into the weight-bearing surface, proximally near the heel, and distally to the midfoot. Panel B shows the flap elevated with the medial plantar artery and nerve visible in the pedicle, maintaining sensory innervation. Panel C shows the flap rotated posteriorly into a heel defect, with the specialized glabrous plantar skin now covering the weight-bearing heel surface. The donor site is shown closed primarily or with a skin graft. Labels identify the medial plantar artery, medial plantar nerve, abductor hallucis, posterior tibial artery, and the weight-bearing and non-weight-bearing zones of the plantar surface.</image>

## Amputation Levels
**Toe amputation**: for gangrenous or infected individual toes; preserve as much length as possible. **Ray amputation**: toe plus metatarsal; first ray loss causes significant gait disturbance; central ray loss better tolerated. **Transmetatarsal amputation (TMA)**: preserves a functional foot for ambulation; requires adequate plantar flap and vascular supply; Achilles lengthening often performed concurrently to prevent equinus. **Midfoot amputation** (Chopart, Lisfranc): historically high complication rates; equinovarus deformity common without tendon balancing.

**Below-knee amputation (BKA)**: when foot salvage is not possible; preserves the knee joint for prosthetic ambulation. **Priority**: preserve the knee joint; BKA patients achieve functional ambulation in 70-80% compared to 30-40% for above-knee amputees.

## Prevention and Long-Term Management
Annual comprehensive foot examination for all diabetic patients. Therapeutic footwear: extra-depth shoes, custom molded insoles, rocker-bottom soles to reduce plantar pressure. Patient education: daily foot inspection, proper nail care, avoidance of barefoot walking, moisture management. Multidisciplinary diabetic foot clinic follow-up. Recurrence rate for healed DFUs: 40% at 1 year, 65% at 5 years; lifelong surveillance is essential.

## Key Clinical Pearls
Peripheral sensory neuropathy is the single most important risk factor for diabetic foot ulceration; loss of protective sensation (inability to detect 10g Semmes-Weinstein monofilament) identifies patients at highest risk who need aggressive preventive measures. Vascular assessment is essential before any reconstruction; diabetic patients have predominantly infrapopliteal disease with falsely elevated ABIs due to calcification; use toe pressures (TBI >0.7) or TcPO2 (>40 mmHg) for reliable perfusion assessment. Offloading with a total contact cast is the gold standard non-operative treatment for plantar neuropathic ulcers and achieves healing in 70-90% of cases; it should be attempted before surgical reconstruction. Percutaneous Achilles tendon lengthening for equinus contracture reduces forefoot plantar pressure by 27% and significantly reduces ulcer recurrence; it should be performed concurrently with forefoot reconstruction. The medial plantar (instep) flap is the gold standard local flap for heel reconstruction because it provides glabrous, sensate, durable tissue uniquely suited for weight-bearing; however, adequate perfusion from the posterior tibial artery must be confirmed preoperatively.

## References
- Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375.
- Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. J Bone Joint Surg Am. 2003;85(8):1436-1445.
- Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117(7 Suppl):72S-109S.
- Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-1293.